Sabbagh Marwan Insider Trades

Insider Trading History

Track insider trading activity for Sabbagh Marwan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
CervoMed
CervoMed CRVO
Director
Holding Value $30.3k 8,150 shares
Last Trade
Jun 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.7k 8,150 shares
$2.91
$3.72
CervoMed
CervoMed CRVO
Director
Holding Value $30.1k 8,100 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.8k 8,100 shares
$6.52
$3.72
CervoMed
CervoMed CRVO
Director
Holding Value $21.4k 5,750 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$109k 5,750 shares
$19.01
$3.72
CervoMed
CervoMed CRVO
Director
Holding Value $24k 6,450 shares
Last Trade
Sep 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.4k 6,450 shares
$5.33
$3.72
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals DFFN
Director
Holding Value $28.4k 6,450 shares
Last Trade
Sep 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.4k 6,450 shares
$4.40
$4.40
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals DFFN
Director
Holding Value $0 0 shares
Last Trade
Aug 16, 2023 Sale
$20.3k 4,604 shares
$4.40
$4.40
Cortexyme
Cortexyme CRTX
Director
Holding Value $43k 22,058 shares
Last Trade
Mar 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$106k 22,058 shares
$4.79
$1.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up